AVERI KEMPF: Open Payments
NPI 1144531880 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 44 payments from 14 companies in 2025. Trend: 2023 $570 · 2024 $801 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $157 |
| GlaxoSmithKline, LLC. | 8 | $137 |
| Novo Nordisk Inc | 5 | $76 |
| ABBVIE INC. | 3 | $52 |
| Lilly USA, LLC | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| Currax Pharmaceuticals LLC | 3 | $43 |
| C2N Diagnostics, LLC | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
Products named: TRELEGY ELLIPTA, EVENITY, OTEZLA, MOUNJARO, SHINGRIX, XIFAXAN, CONTRAVE, Wegovy.
Industry payments across NC — which companies pay providers there.
